Europe’s Medical Authority to use ‘safer’ longer approval vaccine process

The European Union’s drug regulator said on Wednesday that its longer approval process for COVID-19 vaccines was safer, after Britain granted an emergency authorisation to the experimental shot being developed by Pfizer and BioNTech.

Asked about the UK approval of the Pfizer vaccine, the European Medicines Agency said: “EMA considers that the conditional marketing authorisation is the most appropriate regulatory mechanism for use in the current pandemic emergency.” It said that procedure was based on more evidence and more checks than the emergency procedure chosen by Britain.

UK approves Pfizer Biotech vaccine
Britain approves Pfizer-BioNTech vaccine for use